#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute graft versus host disease in liver Alternating hemiplegia of childhood Immunodeficiency Cutaneous T-cell lymphoma stage I Neuromyelitis optica spectrum disorder Hypereosinophilic syndrome Haemophilia A with anti factor VIII Heritable pulmonary arterial hypertension Immune-mediated enterocolitis Intracranial germ cell tumour Facioscapulohumeral muscular dystrophy Primary adrenal insufficiency Alagille syndrome Giant cell tumour of tendon sheath Primary myelofibrosis More trials…

    Learn about Rare Diseases

    Phenylketonuria – Life with Disease Marginal zone lymphoma – Treatment Sjogren’s syndrome – Trials in Disease Ornithine transcarbamoylase deficiency – Basic Information Hepatic angiosarcoma – Diagnostics Angiosarcoma recurrent – Trials in Disease Idiopathic inflammatory myopathy Antisynthetase syndrome – Diagnostics Hereditary optic atrophy Testicular leiomyosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Valsartan R-Azasetron Besilate Alectinib Hydrochloride ATUMELNANT Lucerastat [14C]ZIPALERTINIB Damoctocog Alfa Pegol Ipratropium Bromide Darolutamide Neostigmine Methylsulfate Fosamprenavir Calcium Ribonucleic Acid K30 Diphenhydramine Hydrochloride Buprenorphine Rbl005.3 Tak-280 Talquetamab Sodium Iodide (131I) Nafarelin Sodium Fluoride (18F) More therapies…

    Learn about Your Condition

    Gingival bleeding Macular oedema Dizziness Hepatic adenoma Rasmussen encephalitis Ocular hypertension Mesothelioma malignant Dystonia Colon cancer metastatic Alport's syndrome Acquired ATTR amyloidosis Antisynthetase syndrome Infertility female Benign renal neoplasm Cartilage injury More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of Sacituzumab Govitecan for Patients with Advanced or Metastatic Bladder Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Transitional cell cancer of the renal pelvis and ureter
    Investigated Drugs:
    • Avelumab
    • Domvanalimab
    • Zimberelimab
    France Germany Greece Italy Spain

  • Study Comparing Amoxicillin and Amoxicillin/Clavulanic Acid for Treating Community-Acquired Pneumonia in Patients Aged 65 and Older

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Amoxicillin
    • Clavulanic Acid
    France

  • Study Comparing Short-Course Radiotherapy and Drug Combination for Older Patients with Locally Advanced Rectal Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Metoclopramide
    • Capecitabine
    • Dexamethasone
    Belgium

  • Study on MBK-01 and Drug Combination for Treating Patients with Recurrent Diverticulitis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Diverticulitis
    Investigated Drugs:
    • Amoxicillin
    • Allogeneic Faecal Microbiota, Pooled
    • Fosfomycin
    Spain

  • Study on Alpelisib for Treating Lymphatic Malformations in Patients with PIK3CA Mutation

    Recruiting

    4 1
    Investigated Diseases:
    • Lymphangioma
    Investigated Drugs:
    • Alpelisib
    Belgium Czechia France Germany Italy The Netherlands +1

  • Study Comparing Drug-Coated Balloon and Drug-Eluting Stents in Patients with Coronary Artery Disease at High Risk of Bleeding Using Acetylsalicylic Acid and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Coronary artery disease
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    • Prasugrel
    Finland France Spain
Previous Page
1 … 562 563 564 565 566 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!